As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|April 1, 2005
- Volume 0 0
Council to Enhance Pharmacy
Advertisement
The National Association of ChainDrug Stores (NACDS) has formed a newcouncil to improve the value and significanceof the retail pharmacy industry,as well as the interaction betweenpharmacists and their patients. TheNACDS Pharmacy Industry Council(PIC) will provide a forum to identifyand address common issues and challengespeculiar to the pharmacy industry,while communicating with theNACDS Board of Directors, councilmember companies, and other pharmacyorganizations and policy makers.
The PIC has 21 associate membersand 11 retailers, with 3 subcommitteeson the importance of pharmacy, technology,and the supply chain. Theleadership will focus on pharmacyissues, encourage member participation,and aid the development of programsthat will be beneficial to allNACDS members.
Articles in this issue
over 21 years ago
Internet Prescribing 2005over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Breakfast Cereals Take a Step in the Right Directionover 21 years ago
Refined Carbs Cause Obesityover 21 years ago
Obesity Problematic for Young Transplant Patientsover 21 years ago
High BMI Linked to Dementiaover 21 years ago
When Does Compounding Become Manufacturing?over 21 years ago
Talking to Your Diabetes Patients About Fiberover 21 years ago
Counseling Guide for Avoiding Asthma Triggersover 21 years ago
RA Drug Does Not Alter Cholesterol RatioAdvertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Precision in Practice: Biomarker Testing and Treatment Selection in Primary Advanced or Recurrent Endometrial Cancer
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5